These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 12629519

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intracellular expression of a single-chain antibody directed to the EGFR leads to growth inhibition of tumor cells.
    Jannot CB, Beerli RR, Mason S, Gullick WJ, Hynes NE.
    Oncogene; 1996 Jul 18; 13(2):275-82. PubMed ID: 8710366
    [Abstract] [Full Text] [Related]

  • 3. Validation of a stable recombinant antibodies repertoire for the direct selection of functional intracellular reagents.
    Villani ME, Di Carli M, Donini M, Traversini G, Lico C, Franconi R, Benvenuto E, Desiderio A.
    J Immunol Methods; 2008 Jan 01; 329(1-2):11-20. PubMed ID: 17980894
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A universal strategy for stable intracellular antibodies.
    Shaki-Loewenstein S, Zfania R, Hyland S, Wels WS, Benhar I.
    J Immunol Methods; 2005 Aug 01; 303(1-2):19-39. PubMed ID: 16045924
    [Abstract] [Full Text] [Related]

  • 6. Intrabodies against the EVH1 domain of Wiskott-Aldrich syndrome protein inhibit T cell receptor signaling in transgenic mice T cells.
    Sato M, Iwaya R, Ogihara K, Sawahata R, Kitani H, Chiba J, Kurosawa Y, Sekikawa K.
    FEBS J; 2005 Dec 01; 272(23):6131-44. PubMed ID: 16302976
    [Abstract] [Full Text] [Related]

  • 7. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G, Visintin M, Cannistraci I, Cattaneo A.
    J Mol Biol; 2009 Apr 03; 387(3):584-606. PubMed ID: 19361429
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Platelet integrin alpha2 I-domain specific antibodies produced via domain specific DNA vaccination combined with variable gene phage display.
    Hughes DL, Stafford P, Hamaia SW, Harmer lJ, Schoolmeester A, Deckmyn H, Farndale RW, Ouwehand WH, Watkins NA.
    Thromb Haemost; 2005 Dec 03; 94(6):1318-26. PubMed ID: 16411412
    [Abstract] [Full Text] [Related]

  • 12. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
    Villani ME, Morea V, Consalvi V, Chiaraluce R, Desiderio A, Benvenuto E, Donini M.
    Mol Immunol; 2008 May 03; 45(9):2474-85. PubMed ID: 18313757
    [Abstract] [Full Text] [Related]

  • 13. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
    Wang Y, Li X, Chen W.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan 03; 26(1):16-21. PubMed ID: 16495168
    [Abstract] [Full Text] [Related]

  • 14. Construction and characterization of recombinant single-chain variable fragment antibodies against Toxoplasma gondii MIC2 protein.
    Hoe LN, Wan KL, Nathan S.
    Parasitology; 2005 Dec 03; 131(Pt 6):759-68. PubMed ID: 16336729
    [Abstract] [Full Text] [Related]

  • 15. Isolation of tumor cell-specific single-chain Fv from immunized mice using phage-antibody libraries and the re-construction of whole antibodies from these antibody fragments.
    Kettleborough CA, Ansell KH, Allen RW, Rosell-Vives E, Güssow DH, Bendig MM.
    Eur J Immunol; 1994 Apr 03; 24(4):952-8. PubMed ID: 8149964
    [Abstract] [Full Text] [Related]

  • 16. A basic peptide within the juxtamembrane region is required for EGF receptor dimerization.
    Aifa S, Aydin J, Nordvall G, Lundström I, Svensson SP, Hermanson O.
    Exp Cell Res; 2005 Jan 01; 302(1):108-14. PubMed ID: 15541730
    [Abstract] [Full Text] [Related]

  • 17. Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.
    Perera RM, Narita Y, Furnari FB, Gan HK, Murone C, Ahlkvist M, Luwor RB, Burgess AW, Stockert E, Jungbluth AA, Old LJ, Cavenee WK, Scott AM, Johns TG.
    Clin Cancer Res; 2005 Sep 01; 11(17):6390-9. PubMed ID: 16144944
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.